LMAT Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$118.75median target· current $101.32 (+17.2%)9 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio37.25Forward 33.78
EPS (TTM)$2.7241.7% YoY
Profit margin24.3%HEALTHCARE
Market cap$2.32BMid cap
Valuation
- Forward P/E
- 33.78
- PEG ratio
- 2.81
- P/B
- 5.69
- P/S (TTM)
- 9.03
- EV/EBITDA
- 22.20
Profitability & growth
- ROE (TTM)
- 16.6%
- Operating margin
- 26.7%
- Revenue growth YoY
- 11.2%
- Dividend yield
- 0.8%
- Beta
- 0.52
Last earnings
May 5, 2026 · Estimate $0.66 · Reported $0.68
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About LeMaitre Vascular Inc
Company profileLeMaitre Vascular, Inc. designs, markets, sells, services and supports medical devices and implants for the treatment of peripheral vascular diseases worldwide. The company is headquartered in Burlington, Massachusetts.
Classification
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 63 SECOND AVENUE, BURLINGTON, MA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$2.32B
Shares outstanding$22.9M
52W high$117.72
52W low$79.02
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent